These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6494391)

  • 1. Apomorphine does not lower the concentration of homovanillic acid in the plasma of normal humans.
    Scheinin M
    Psychopharmacol Bull; 1984; 20(4):660-6. PubMed ID: 6494391
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of apomorphine infusion on plasma homovanillic acid in normal subjects.
    Davidson M; Kendler KS; Mohs RC; Hollander E; Ryan T; Davis KL
    J Psychiatr Res; 1986; 20(2):131-5. PubMed ID: 3735141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patients.
    Cutler NR; Jeste DV; Karoum F; Wyatt RJ
    Life Sci; 1982 Mar; 30(9):753-6. PubMed ID: 7070229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
    Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM
    Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients.
    Doran AR; Pickar D; Labarca R; Douillet P; Wolkowitz OM; Thomas JW; Roy A; Paul SM
    Psychopharmacol Bull; 1985; 21(3):694-7. PubMed ID: 4034886
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

  • 9. Sex differences in plasma homovanillic acid in acute psychosis.
    Bowers MB; Swigar ME; Jatlow PI
    N Engl J Med; 1983 Apr; 308(14):845-6. PubMed ID: 6835278
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of plasma homovanillic acid as an index of brain dopamine function.
    Kendler KS; Hsieh JY; Davis KL
    Psychopharmacol Bull; 1982 Oct; 18(4):152-5. PubMed ID: 7156280
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homovanillic acid concentration and the severity of schizophrenic illness.
    Davis KL; Davidson M; Mohs RC; Kendler KS; Davis BM; Johns CA; DeNigris Y; Horvath TB
    Science; 1985 Mar; 227(4694):1601-2. PubMed ID: 3975630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous quantification of 4-hydroxy-3 methoxy phenylacetic acid and 4-hydroxy-3-methoxy mandelic acid in human plasma by mass fragmentography using deuterium-labelled internal standards (author's transl)].
    Girault J; Lefebvre MA; Fourtillan JB; Courtois P; Gombert J
    Ann Pharm Fr; 1981 Feb; 38(5):439-46. PubMed ID: 7212572
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of CCK-33 on prolactin and apomorphine-induced growth hormone secretion in man.
    Nair NP; Lal S; Lizondo E; Eugenio H; Guyda H
    Horm Metab Res; 1983 Jul; 15(7):357-9. PubMed ID: 6884978
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of homovanillic acid in human plasma by high-performance liquid chromatography with electrochemical detection.
    Harris PQ; Bacopoulos NG; Brown SJ
    J Chromatogr; 1984 Aug; 309(2):379-84. PubMed ID: 6480790
    [No Abstract]   [Full Text] [Related]  

  • 18. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL
    Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of homovanillic acid and determination of its production rate in humans.
    Elchisak MA; Polinsky RJ; Ebert MH; Kopin IJ
    J Neurochem; 1982 Feb; 38(2):380-5. PubMed ID: 7108544
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
    Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.